Results 141 to 150 of about 13,320 (251)

Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention. [PDF]

open access: yesMol Cancer Ther, 2019
Mallery SR   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy